MV Capital Management Inc. lifted its stake in Centene Co. (NYSE:CNC – Free Report) by 0.6% in the 4th quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 31,889 shares of the company’s stock after buying an additional 202 shares during the period. MV Capital Management Inc.’s holdings in Centene were worth $1,932,000 as of its most recent filing with the Securities and Exchange Commission.
A number of other large investors have also added to or reduced their stakes in CNC. Capital Advisors Ltd. LLC lifted its position in shares of Centene by 75.3% during the 4th quarter. Capital Advisors Ltd. LLC now owns 412 shares of the company’s stock valued at $25,000 after acquiring an additional 177 shares during the period. Rialto Wealth Management LLC bought a new stake in Centene during the fourth quarter worth about $30,000. OFI Invest Asset Management bought a new position in Centene in the 4th quarter valued at about $33,000. SRS Capital Advisors Inc. raised its position in shares of Centene by 73.4% in the 4th quarter. SRS Capital Advisors Inc. now owns 631 shares of the company’s stock valued at $38,000 after buying an additional 267 shares in the last quarter. Finally, Riverview Trust Co boosted its position in shares of Centene by 172.7% during the 4th quarter. Riverview Trust Co now owns 758 shares of the company’s stock worth $46,000 after acquiring an additional 480 shares in the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.
Analyst Upgrades and Downgrades
Several research analysts have commented on the stock. UBS Group upgraded shares of Centene from a “neutral” rating to a “buy” rating and boosted their price objective for the company from $79.00 to $80.00 in a research report on Friday, December 13th. Jefferies Financial Group downgraded Centene from a “hold” rating to an “underperform” rating and dropped their price objective for the stock from $68.00 to $52.00 in a research report on Tuesday, December 10th. Cantor Fitzgerald reiterated an “overweight” rating and issued a $90.00 target price on shares of Centene in a research report on Wednesday, December 11th. Robert W. Baird raised their price target on shares of Centene from $66.00 to $71.00 in a research note on Tuesday, February 4th. Finally, Truist Financial lowered their price objective on shares of Centene from $89.00 to $84.00 and set a “buy” rating for the company in a research report on Friday, December 13th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and ten have assigned a buy rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and an average target price of $79.92.
Centene Stock Performance
Shares of Centene stock opened at $59.96 on Friday. The stock has a market cap of $29.74 billion, a price-to-earnings ratio of 9.61, a P/E/G ratio of 0.80 and a beta of 0.40. The company has a quick ratio of 1.10, a current ratio of 1.11 and a debt-to-equity ratio of 0.70. Centene Co. has a twelve month low of $55.03 and a twelve month high of $80.59. The company’s fifty day moving average is $59.94 and its 200 day moving average is $62.79.
Centene (NYSE:CNC – Get Free Report) last issued its quarterly earnings results on Tuesday, February 4th. The company reported $0.80 earnings per share for the quarter, beating the consensus estimate of $0.49 by $0.31. The company had revenue of $40.81 billion during the quarter, compared to analysts’ expectations of $38.78 billion. Centene had a return on equity of 13.85% and a net margin of 2.03%. The business’s quarterly revenue was up 3.4% on a year-over-year basis. During the same quarter in the prior year, the firm posted $0.45 earnings per share. Sell-side analysts forecast that Centene Co. will post 6.86 EPS for the current year.
About Centene
Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.
Featured Articles
- Five stocks we like better than Centene
- How to Calculate Retirement Income: MarketBeat’s Calculator
- 4 Healthcare Stocks With Massive Gains—and More to Come
- Find and Profitably Trade Stocks at 52-Week Lows
- Affirm Strikes Back: Can a New Deal Mitigate the Recent Loss?
- Bank Stocks – Best Bank Stocks to Invest In
- Why Dollar Tree’s Family Dollar Sale Could Spark a Comeback
Want to see what other hedge funds are holding CNC? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Centene Co. (NYSE:CNC – Free Report).
Receive News & Ratings for Centene Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Centene and related companies with MarketBeat.com's FREE daily email newsletter.